Literature DB >> 16010646

Use of alternative medicine by patients with stage 5 chronic kidney disease.

Jerrilynn D Burrowes1, Gloria Van Houten.   

Abstract

The use of complementary and alternative medicine (CAM) in the United States is growing at a remarkable speed. Herbal products and dietary supplements are CAM therapies that have grown faster than any other CAM treatments. Little information is available about herbs and dietary supplement use in the stage 5 chronic kidney disease population. These products contain a myriad of pharmacologically active compounds that, when used by people with kidney disease, may be hazardous. Members of the renal dietitian listserv were queried about herbs and dietary supplements reportedly used by dialysis patients. Up-to-date information on the use, safety, efficacy, adverse effects, and recommended dosages in the nondialysis population are presented for 24 products. In the dialysis population, Noni juice should be avoided because of its high potassium content. In addition, bulk-forming laxatives such as flaxseed should be used with caution because of the need for increased fluid intake. Dialysis practitioners should include specific questions about herbs and dietary supplement use in medical and nutrition histories, and they should increase their knowledge about these products to advise patients appropriately. A list of reliable sources of information for the health care provider on herbs and dietary supplements is also presented.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16010646     DOI: 10.1016/j.ackd.2005.04.001

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  5 in total

1.  Differential diagnosis of hyperkalemia: an update to a complex problem.

Authors:  T Eleftheriadis; K Leivaditis; G Antoniadi; V Liakopoulos
Journal:  Hippokratia       Date:  2012-10       Impact factor: 0.471

Review 2.  Reiki and related therapies in the dialysis ward: an evidence-based and ethical discussion to debate if these complementary and alternative medicines are welcomed or banned.

Authors:  Martina Ferraresi; Roberta Clari; Irene Moro; Elena Banino; Enrico Boero; Alessandro Crosio; Romina Dayne; Lorenzo Rosset; Andrea Scarpa; Enrica Serra; Alessandra Surace; Alessio Testore; Nicoletta Colombi; Barbara Giorgina Piccoli
Journal:  BMC Nephrol       Date:  2013-06-21       Impact factor: 2.388

3.  Effects of flaxseed derivatives in experimental polycystic kidney disease vary with animal gender.

Authors:  Malcolm R Ogborn; Evan Nitschmann; Neda Bankovic-Calic; Hope A Weiler; Harold M Aukema
Journal:  Lipids       Date:  2006-12       Impact factor: 1.646

4.  Use of complementary and alternative medicines in haemodialysis patients: a cross-sectional study from Palestine.

Authors:  Sa'ed H Zyoud; Samah W Al-Jabi; Waleed M Sweileh; Ghada H Tabeeb; Nora A Ayaseh; Mayas N Sawafta; Razan L Khdeir; Diana O Mezyed; Dala N Daraghmeh; Rahmat Awang
Journal:  BMC Complement Altern Med       Date:  2016-07-11       Impact factor: 3.659

5.  Heat-processed ginseng saponin ameliorates the adenine-induced renal failure in rats.

Authors:  Eun Jin Kim; Hyun-A Oh; Hyuck Jai Choi; Jeong Hill Park; Dong-Hyun Kim; Nam Jae Kim
Journal:  J Ginseng Res       Date:  2013-03       Impact factor: 6.060

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.